Capitol Health shifted from a previous year's loss of $15.1 million to a profit of $2.4 million for the first half of FY24.

The turnaround is attributed to initiatives like the acquisition of FMIG, Medicare benefits indexation, and operational efficiencies such as new clinic openings.

The company reported a 20.1% revenue increase to $117.8 million and a 21.4% rise in operating EBITDA to $23.9 million for the first half of FY24.

Capitol Health declared a fully franked interim dividend of 0.5 cents per share, maintaining the level from the final dividend in FY23.